UGT2B24P

Across TCGA pan-cancer cohorts, UGT2B24P RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of UGT2B24P’s most consistent transcriptional readouts.

The strongest signal is observed in cholangiocarcinoma (CHOL), where UGT2B24P RNA is repressed in tumor relative to normal tissue. In most cancer types UGT2B24P is over-expressed in tumor, although a few such as CHOL and KIRP show the opposite, repressed pattern.

CHOL, KIRP, and LIHC are the cancer types where UGT2B24P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in UGT2B24P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
CHOL	Female	All	−0.596	<.001	3	view →
KIRP	All	All	−0.186	.026	2	view →
LIHC	All	All	−0.122	.012	2	view →
PRAD	All	All	+0.024	.020	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

UGT2B24P–CHOL

Open the CHOL breakdown →